These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4948222)

  • 1. Activity against M. leprae of lincomycin and two derivatives, of amicetin, phosphonomycin and two derivatives of tetrahydronaphthylaminopropylpiperidine.
    Shepard CC; Van Landingham RM; Redus MA; Walker LL
    Int J Lepr Other Mycobact Dis; 1971; 39(3):742-4. PubMed ID: 4948222
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activation of phosphonomycin by gamma-globulin].
    Raab W; Windisch J
    Arzneimittelforschung; 1973 Aug; 23(8):1029-30. PubMed ID: 4128970
    [No Abstract]   [Full Text] [Related]  

  • 3. Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1969; 37(4):389-97. PubMed ID: 4918202
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correlation between structure and antibacterial activity in a series of azo derivatives of salicylic and alpha-oxynaphtholic acid].
    Rudzit ZA; Mukhina NA; Galanova RIa; Kivman GIa
    Farmakol Toksikol; 1969; 32(4):449-51. PubMed ID: 4391081
    [No Abstract]   [Full Text] [Related]  

  • 5. Phosphonomycin (MK-955). Quantitative sensitivity spectra of various hospital strains to this new antibiotic.
    Moreno-López M; Dámaso D; Perea EJ; Sousa AS; Martínez L; Marco L
    Microbiol Esp; 1971; 24(2):79-85. PubMed ID: 5135048
    [No Abstract]   [Full Text] [Related]  

  • 6. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lincomycin, clindamycin and their applications.
    Spízek J; Rezanka T
    Appl Microbiol Biotechnol; 2004 May; 64(4):455-64. PubMed ID: 14762701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of C1. perfringens resistance to lincomycin].
    Miasnikova LG
    Antibiotiki; 1976 Feb; 21(2):138-41. PubMed ID: 179463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
    Dhople AM; Dimova V
    Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus].
    Wiedemann B
    Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activity of lincomycin hydrochloride against pathogenic staphylococci].
    Cluzel M; Jouve P; Vaurs R; Cluzel R
    C R Seances Soc Biol Fil; 1967; 161(10):1997-2001. PubMed ID: 4234187
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA; Gardner GD
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.
    Franzblau SG
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1232-4. PubMed ID: 1929269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled clinical trial for evaluation of antimicrobial drug activity against M. leprae.
    Grosset JH; Ji BH
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):529-31. PubMed ID: 2664047
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in the chemotherapy of leprosy].
    Grosset J
    Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the bactericidal activity of a series of rifampicins against Mycobacterium leprae.
    Pattyn SR
    Arzneimittelforschung; 1982; 32(1):15-7. PubMed ID: 7037013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of resistance-factor transfer by clindamycin and its analogues.
    Roeser J
    Antimicrob Agents Chemother (Bethesda); 1968; 8():41-7. PubMed ID: 4898535
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sensitivity of hospital strains of Staphylococcus aureus to lincomycin and clindamycin].
    Jakubicz P; Dzierzanowska D
    Pol Tyg Lek; 1980 Feb; 35(8):269-71. PubMed ID: 7360703
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculostatic effect in vitro of certain new antibiotics (amikin, dalacin C, clindamycin, netromycin, tobramycin, lincomycin) on mycobacteria, particularly on M. avium.
    Sula L; Sulová J
    Czech Med; 1984; 7(2):122-8. PubMed ID: 6430657
    [No Abstract]   [Full Text] [Related]  

  • 20. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.